Vaccinations with Live Attenuated Virus Vaccines: Immunoglobulin administration may impair the efficacy of live attenuated virus vaccines eg, measles, rubella, mumps and varicella vaccines for a period of up to 3 months. After administration of Berirab P an interval of at least 3 months should elapse before vaccination with live virus vaccines. In the case of measles, this impairment may persist for up to 4 months. Therefore, patients receiving measles vaccine should have their antibody status checked.
Interference with Serological Testing: It has to be considered that when serological test results are interpreted, the transitory rise of passively transferred antibodies after immunoglobulin injection may result in misleading positive test results.
Passive transmission of antibodies to erythrocyte antigens eg, A, B and D may interfere with some serological tests for red cell allo-antibodies (eg, Coombs test).
Incompatibilities: In the absence of compatibility studies, Berirab P must not be mixed with other medicinal products, diluents or solvents.